mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.002 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.002 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.003 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.004 |